Clinical Pathways Search Results

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

This pathway guides care of patients in the Emergency Department and inpatient units coming to the General Operating Rooms and radiologic procedures under Anesthesia/sedation.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

Guides medical, environmental and ongoing management for children with venous blood lead levels ≥ 3.5 μg/dL.

This pathway guides clinicians in laboratory studies and appropriate consultation to Bone Health team as needed, with a goal to prevent any fractures from occurring while children are in the hospital.

This pathway provides guidance for the care of all patients who have sustained a traumatic injury with risk to life or limb. Patients with recognized life threatening injuries are classified as Trauma Level One or Trauma Level Two and require initial evaluation and resuscitation in the Trauma Bay.

This pathway is intended for Emergency Department patients requiring procedural sedation who are healthy or those with mild systemic disease that is well controlled.

The inpatient anaphylaxis pathway takes a step-by-step approach to the evaluation and treatment of a child with a of history anaphylaxis.

The anaphylaxis pathway highlights the care necessary in treating children with anaphylaxis in an outpatient setting.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.